(12) United States Patent (10) Patent No.: US 7.416,744 B2 Rubin Et Al
USOO741674.4B2 (12) United States Patent (10) Patent No.: US 7.416,744 B2 Rubin et al. (45) Date of Patent: *Aug. 26, 2008 (54) EXTRACTS, COMPOUNDS AND 5,252,572 A 10, 1993 Hermecz et al. PHARMACEUTICAL COMPOSITIONS 5,270,342 A 12/1993 Brittain et al. HAVING ANT-DABETIC ACTIVITY AND 5,364,636 A 11, 1994 Ochi THEIR USE 5.430,060 A 7/1995 Brittain et al. 5.447,946 A 9, 1995 Kurono et al. 5,504,078 A 4/1996 Ducepetal. (75) Inventors: Ian Duncan Rubin, Nottingham (GB); 5,516,516 A 5/1996 Cherksey Jasjit Singh Bindra, Groton, CT (US); 5,605,698 A 2, 1997 Ueno Michael Anthony Cawthorne, Milton 5,693,327 A 12, 1997 Shah Keynes (GB) 5,698,199 A 12/1997 Mori et al. 5,728,704 A 3/1998 Mylarietal. (73) Assignee: Conopco, Inc., Englewood Cliffs, NJ 5,798, 101 A 8, 1998 Haveson (US) 5,824,668 A 10, 1998 Rubinfeld et al. 5,866.578 A 2/1999 Mylarietal. (*) Notice: Subject to any disclaimer, the term of this 5,908,609 A 6/1999 Lee et al. patent is extended or adjusted under 35 6,100,048 A 8, 2000 Cone et al. 6,309,853 B1 10/2001 Friedman et al. U.S.C. 154(b) by 0 days. 6,376,657 B1 4/2002 Van Heerden et al. 6,488.967 B1 12/2002 Hakkinen et al. This patent is Subject to a terminal dis 7,033,616 B2 * 4/2006 Rubinet al.
[Show full text]